Narrative reviewindependent cross-checkfull text checked I-FAST-05 in-depth review
What intermittent fasting does to metabolism
Metabolic Effects of Intermittent Fasting.
Overview
Patterson RE et al.. Annu Rev Nutr 2017 · PMID 28715993 · DOI 10.1146/annurev-nutr-071816-064634
Fasting regimens seem to help weight loss and may improve metabolism; much is still hypothesis.
Does the study support the specific claim? Partly · Methodological quality: low
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Metabolic effects of intermittent fasting
- How was the study done?
Narrative review
- How many people, animals or samples were studied?
not applicable; Humans and animal models
- What was actually found?
Most small fasting trials showed some weight loss; fasting was not better than eating less every day; benefits for liver and metabolism come mainly from mouse studies.
- How large was the observed effect?
not reported
- What do the results mean in everyday life?
A possible tool, not a cure.
- What are the study's limitations?
Not a systematic review; small, short human studies; much evidence from male mice; no long-term disease outcomes.
- What does it say about Elawady's specific claim?
Partial support for C-FAST-02, C-FAST-05; kernel of C-FAST-01.
- Do the results apply to Germany and Europe?
General.
- What can explicitly not be concluded from this study?
Superiority or detox effects.
Scientific in-depth review
1. Full reference
- Authors
- Patterson RE et al.
- Journal
- Annu Rev Nutr
- Year
- 2017
- Identifier
- PMID 28715993 DOI 10.1146/annurev-nutr-071816-064634
- Verification
- verified – PubMed efetch 2026-10-25 (this agent)
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
Supported in part by the National Cancer Institute TREC centres grant U54CA155435; authors report no affiliations or holdings perceived as affecting objectivity.
2. Research question
Metabolic effects of intermittent fasting
3. Study design and population
- Study design
- Narrative review – Narrative review (explicitly 'not a formal review or a meta-analysis') of animal studies, human intervention trials (alternate-day fasting, modified fasting, time-restricted feeding), religious fasting and observational studies; PubMed search plus reference lists; no quality appraisal or pooling.
- Population
Rodent models (mostly male mice) and adults in small human trials (n=8-107) and observational studies.
- Country
USA
- Period
To 2017
- Sample size
16 human intervention trials tabulated (3 alternate-day fasting, 9 modified fasting, 4 time-restricted feeding), most with <50 participants and durations of 1 day to 6 months; plus meta-analyses of Ramadan studies and selected cohort analyses.
- Inclusion and exclusion criteria
Human studies: randomised or non-randomised trials in adults with endpoints of body weight or biomarkers of diabetes, CVD or cancer risk; religious fasting summarised separately.
4. Methods and endpoints
- Exposure / intervention
Intermittent fasting regimens
- Comparator
not applicable
- Endpoints
Metabolic health
- Statistical methods
Descriptive narrative synthesis; no meta-analysis.
5. Actual results
- Results
11 of 16 human trials reported significant weight loss. Alternate-day fasting (3 small studies, 15-22 days or 1 day): some weight loss and lower glucose/insulin, but intense hunger. Modified fasting (9 trials): weight loss in 7/9 (3.2% vs control over 12 weeks to 8.0% in an 8-week one-arm trial); insulin reduced in 3/6, glucose in 1, lipids improved in 3/8, inflammatory markers in 3/6. In comparisons with continuous energy restriction, fasting was superior for weight in only 1 of 3 trials; reviews/meta-analyses unanimously found no superiority. Time-restricted feeding: 4 small human trials with mixed results (incl. one 15-person 8-week crossover of one meal per day with 4.1% weight loss; a 6-week breakfast-skipping trial with no benefit). Ramadan meta-analysis: -1.24 kg (95% CI -1.60 to -0.88) during Ramadan with 0.72 kg regained within 2 weeks. WHEL cohort: nightly fast <13 h associated with breast cancer recurrence HR 1.36 (1.05-1.76). Rodent data suggest reduced liver steatosis and metabolic benefits.
- Absolute risks
not reported in full text (narrative review).
- Authors' conclusion
Intermittent fasting regimens appear to produce some weight loss and may improve metabolic health and appear not to be harmful in healthy, normal-weight, overweight or obese adults; alternate-day fasting is not superior to continuous calorie restriction; data on clinical outcomes are limited; large, at least 1-year RCTs are needed; prolonged nightly fasting is a hypothesis supported mainly by animal data.
6. Strengths
- Broad overview including regimens, mechanisms and tabulated human trials
- Authors explicitly acknowledge the limits of the evidence (small, short, heterogeneous trials)
- Public funding; no COI declared
7. Weaknesses
- Non-systematic narrative review: single database, no protocol, no risk-of-bias assessment, no pooling
- Human evidence consists of small, short trials, many uncontrolled; much mechanistic reasoning extrapolated from male rodents
- Authors include their own observational analyses (NHANES, WHEL) - potential emphasis bias
- No data on long-term clinical outcomes; fatty liver and 'detox' benefits shown only in rodents
8. Risk of bias
- Orienting tool
- none applicable (narrative review)
- Type of assessment
- structured assessment based on the full text by a single reviewer (no formal double review)
- Full formal assessment
- no
- Overall risk of bias
- high
- Rationale
No standard tool for narrative reviews; single-reviewer structured judgement from the full text (formal assessment would need two reviewers). Rated high risk of bias as an evidence synthesis (was 'not_assessable'); useful as a hypothesis map, not as evidence of efficacy.
| Domain | Judgement | Rationale |
|---|---|---|
| Search and selection | high | PubMed-only search with broad terms plus reference lists; no flow diagram or explicit selection process. |
| Appraisal of included studies | high | No risk-of-bias or quality assessment of the 16 trials. |
| Synthesis | some concerns | Vote counting of significant results; heterogeneity acknowledged; conclusions generally cautious. |
| Interpretation | some concerns | Mechanistic and rodent evidence presented as 'striking'; human conclusions appropriately hedged ('if proven efficacious'). |
Full-text review (25 October 2026): Methods (PubMed search, 16 trials, not a formal review), per-regimen results, comparison with continuous energy restriction (no superiority), Ramadan meta-analysis and WHEL numbers added; funding (NCI) and no COI added; structured judgement with domains, overall not_assessable -> high; methodological_quality moderate -> low; directness -> indirect; relevance to C-FAST-01/02/05 narrowed.
9. Assessment of the statistical interpretation
Vote counts of small, heterogeneous trials; weight loss from fasting regimens is consistent with reduced energy intake; no evidence of superiority over continuous calorie restriction; no human data on liver 'repair' or detoxification.
10. Relevance to the specific claim
Partial, indirect support for C-FAST-05 (IF regimens produce some weight loss; OMAD studied only in one 15-person crossover); fasting lowers insulin but provides no support for 'insulin equals zero' (C-FAST-01); no human evidence for liver/gut 'repair', detoxification or IF as the only fatty-liver treatment (C-FAST-02).
11. Independent contrary findings
12. Transferability to Germany and Europe
General.
13. Overall methodological judgement
Cautious narrative overview: intermittent fasting can cause modest weight loss and is generally tolerable, but is not superior to daily calorie restriction and lacks long-term outcome data; liver/metabolic 'repair' benefits are largely from rodents.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | low |
| Risk of bias | high |
| Precision of results | not applicable |
| Directness | indirect |
| Reproducibility | partly replicated |
| Consistency with the overall evidence | mixed |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
None beyond those stated.
15. Linked fact checks
- Fasting brings gut hormones, above all insulin, to zero ('your fasting insulin equals zero'). – Studies with mixed or unclear results
- Fasting gives the liver and gut the chance to repair themselves and expel toxins; intermittent fasting is the only treatment for fatty liver and treats joint pain, autoimmune and allergy-like symptoms. – Studies with mixed or unclear results
- Long daily intermittent fasting with one meal a day as the default eating pattern (and sometimes eating once every two days) is the healthy way to eat. – Studies supporting the claim